Broadly distributed T cell reactivity, with no immunodominant loci, to the pre-erythrocytic antigen thrombospondin-related adhesive protein of Plasmodium falciparum in West Africans

European Journal of Immunology

Volumn 29, Issue 6, 1999, Pages 1943-1954

  Flanagan, Katie L ^a   Plebanski, Magdalena ^a   Akinwunmi, Peter ^b   Lee, Edwin A M ^a   Reece, William H H ^a   Robson, Kathryn J H ^a   Hill, Adrian V S ^a   Pinder, Margaret ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

ELISPOT; IFN ; T cell epitope; Thrombospondin related adhesive protein of P. falciparum

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; EPITOPE; ERYTHROCYTE ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; INTERLEUKIN 4; MALARIA VACCINE; PEPTIDE; PROTEIN; THROMBOSPONDIN;

ANIMAL MODEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ASSAY; GAMBIA; HUMAN; HUMAN CELL; IMMUNITY; MALARIA; MALE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SPOROZOITE; T LYMPHOCYTE;

ADULT; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, PROTOZOAN; FEMALE; GAMBIA; HLA-DR ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; INTERFERON TYPE II; MALARIA, FALCIPARUM; MALE; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; T-LYMPHOCYTES; TH2 CELLS;

EID: 0033060652     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199906)29:06<1943::AID-IMMU1943>3.0.CO;2-1     Document Type: Article

References (66)

1. World Health Organisation, Twelfth programme report of the UNDP/World Bank/WHO special programme for research and training in tropical diseases (TDR). Bull. WHO 1995. 12: 64-76.
2. Peters, W., Chemotherapy and drug resistance in malaria. Academic Press, London 1987.
3. Clyde, D. F., Most, H., McCarthy, V. and Vanderberg, J. P., Immunization of man against sporozoite-induced falciparum malaria. Am. J. Med. Sci. 1973. 266: 169-177.
4. Herrington, D., Davis, J., Nardin, E., Beler, M., Cortese, J., Eddy, H., Losonsky, G., Hollingdale, M., Sztein, M., Levine, M., Nussenzweig, R. and Clyde, D., Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals. Am. J. Trop. Med. Hyg. 1991. 45: 539-547.
5. Nussenzweig, V. and Nussenzweig, R., Circumsporozoite proteins of malaria parasites. Cell 1985. 42: 401-403.
6. Malik, A., Egan, J. E., Houghten, R. A., Sadoff, J. C. and Hoffman, S. L., Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. Proc. Natl. Acad. Sci. USA 1991. 88: 3300-3304.
7. Doolan, D. L., Houghten, R. A. and Good, M. F., Location of human cytotoxic T cell epitopes within a polymorphic domain of the Plasmodium falciparum circumsporozoite protein. Int. Immunol. 1991. 3: 511-516.
8. Hill, A. V. S., Elvin, J., Willis, A. C., Aidoo, M., Allsopp, C. E. M., Gotch, F. M., Ming Gao, X., Takiguchi, M., Greenwood, B. M., Townsend, A. R. M., McMichael, A. J. and Whittle, H. C., Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 1992. 360: 434-439.
9. Aidoo, M., Lalvani, A., Allsopp, C. E. M., Plebanski, M., Meisner, S. J., Krausa, P., Browning, M., Morris-Jones, S., Gotch, F., Fidock, D. A., Takiguchi, M., Robson, K. J. H., Greenwood, B. M., Druihle, P., Whittle, H. C. and Hill, A. V. S., Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet 1995. 345: 1003-1007.
10. Good, M. F., Pombo, D., Quakyi, I. A., Riley, E. M., Houghten, R. A., Menon, A., Alling, D. W., Berzofsky, J. A. and Miller, L. H., Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule. Proc. Natl. Acad. Sci. USA 1988. 85: 1199-1203.
11. Zevering, Y., Houghten, R. A., Frazer, I. H. and Good, M. F., Major population differences in T cell response to a malaria sporozoite vaccine candidate. Int. Immunol. 1990. 2: 945-955.
12. + T cells from a sporozoite-immunized volunteer recognize the P. falciparum CS protein. Int. Immunol. 1993. 3: 997-1003.
13. + T cells and antibodies required for immunity to malaria sporozoites. Nature 1987. 330: 664-666.
14. Romero, P., Maryanski, J. L., Corradin, G., Nussenzweig, R. S., Nussenzweig, V. and Zavala, F., Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 1989. 341: 323-326.
15. Weiss, W. R., Berzofsky, J. A., Houghten, R. A., Sedegah, M., Hollindale, M. and Hoffman, S. L., A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei. J. Immunol. 1992. 149: 2103-2109.
16. + T cell clones against Plasmodium yoelii liver stages. J. Immunol. 1993. 150: 1471-1478.
17. + cytotoxic T-cell clone recognizing the sporozoite surface protein 2. Infect. Immun. 1994. 62: 2979-2983.
18. + T cell- and IFN-γ-dependent elimination of infected hepatocytes. J. Immunol. 1996. 157: 4061-4067.
19. + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat. Med. 1998. 4: 397-402.
20. Hoffman, S. L., Oster, C. N., Mason, C., Beier, J. C., Sherwood, J. A., Ballou, W. R., Mugambi, M. and Chulay, J. D., Human lymphocyte proliferative response to a sporozoite T cell epitope correlates with resistance to falciparum malaria. J. Immunol. 1989. 142: 1299-1303.
21. Riley, E. M., Allen, S. J., Bennett, S., Thomas, P. J., O'Donnell, A., Lindsay, S. W., Good, M. F. and Greenwood, B. M., Recognition of dominant T cell-stimulating epitopes from the circumsporozoite protein of Plasmodium falciparum and relationship to malaria morbidity in Gambian children. Trans. R. Soc. Trop. Med. Hyg. 1990. 84: 648-657.
22. Stoute, J. A., Slaoui, M., Gray Heppner, D., Momin, P., Kester, K. E., Desmons, P., Wellde, B. T., Garçon, N., Krzych, U., Marchand, M., Ballou, W. R. and Cohen, J. D., A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. N. Engl. J. Med. 1997. 336: 86-91.
23. Stoute, J., Kester, K. E., Krzych, U., et al., Long-efficacy and immune responses following immunization with the RTS,S malaria vaccine. J. Infect. Dis. 1998. 178: 1139-1144.
24. Hoffman, S. L., Isenbarger, D., Long, G. W., Sedegah, M., Szarfman, A., Waters, L., Hollingdale, M. R., van der Meide, P. H., Finbloom, D. S. and Ballou, W. R., Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes. Science 1989. 244: 1078-1081.
25. Good, M. F., Pombo, D., Maloy, W. L., de la Cruz, V. F., Miller, L. H. and Berzofsky, J. A., Parasite polymorphism present within minimal T cell epitopes of Plasmodium falciparum circumsporozoite protein. J. Immunol. 1988. 140: 1645-1650.
26. Lockyer, M. J., Marsh, K. and Newbold, C. I., Wild isolates of Plasmodium falciparum show extensive polymorphism in T cell epitopes of the circumsporozoite protein. Mol. Biochem. Parasitol. 1989. 37: 275-280.
27. Doolan, D. L., Saul, A. J. and Good, M. F., Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: relevance for vaccine design. Infect. Immun. 1992. 60: 675-682.
28. Shi, Y.-P., Alpers, M. P., Povoa, M. M. and Lal, A. A., Diversity in the immunodominant determinants of the circumsporozoite protein of Plasmodium falciparum parasites from malaria-endemic regions of Papua New Guinea and Brazil. Am. J. Trop. Med. Hyg. 1992. 47: 844-851.
29. Rogers, W. O., Malik, A., Mellouk, S., Nakamura, K., Rogers, M. D., Szarfman, A., Gordon, D. M., Nussler, A. K., Aikawa, M. and Hoffman, S. L., Characterization of Plasmodium falciparum sporozoite surface protein 2. Proc. Natl. Acad. Sci. USA 1992. 89: 9176-9180.
30. Sultan, A. A., Thathy, V., Frevert, U., Robson, K. J. H., Crisanti, A., Nussenzweig, V., Nussenzweig, R. S. and Menard, R., TRAP is necessary for gliding motility and infectivity of sporozoites. Cell 1997. 90: 511-522.
31. Müller, H.-M., Reckmann, I., Hollingdale, M. R., Bujard, H., Robson, K. J. H. and Crisanti, A., Thrombospondin-related anonymous protein (TRAP) of Plasmodium falciparum binds specifically to sulfated glycoconjugates and to HepG2 hepatoma cells suggesting a role for this molecule in sporozoite invasion of hepatocytes. EMBO J. 1993. 12: 2881-2889.
32. Khusmith, S., Charoenvit, Y., Kumar, S., Sedegah, M., Beaudoin, R. L. and Hoffman, S. L., Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. Science 1991. 252: 715-718.
33. Wizel, B., Houghten, R. A., Parker, K. C., Coligan, J. E., Church, P., Gordon, M., Ballou, R. P. and Hoffman, S. L., Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2. J. Exp. Med. 1995. 182: 1435-1445.
34. Wizel, B., Houghten, R. A., Church, P., Tine, J. A., Lanar, D. E., Gordon, D. M., Ballou, W. R., Sette, A. and Hoffman, S. L., HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers. J. Immunol. 1995. 155: 766-775.
35. Doolan, D. L., Hoffman, S. L., Southwood, S., Wentworth, P. A., Sidney, J., Chesnut, R. W., Keogh, E., Apella, E., Nutman, T. B., Lal, A. A., Gordon, D. M., Oloo, A. and Sette, A., Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity 1997. 7: 97-112.
36. Plebanski, M., Aidoo, M., Whittle, H. C. and Hill, A. V. S., Precursor frequency analysis of cytotoxic T lymphocytes to pre-erythrocytic antigens of Plasmodium falciparum in West Africa. J. Immunol. 1997. 158: 2849-2855.
37. Scarselli, E., Tölle, R., Koita, O., Diallo, M., Müller, H.-M., Früh, K., Doumbo, O., Crisanti, A. and Bujard, H., Analysis of the human antibody responses to thrombospondin-related anonymous protein of Plasmodium falciparum. Infect. Immun. 1993. 61: 3490-3495.
38. Maheshwari, R. K., Czarniecki, C. W., Dutta, G. P., Puri, S. K., Dhawan, B. N. and Friedman, R. N., Recombinant human gamma interferon inhibits simian malaria. Infect. Immun. 1986. 53: 628-630.
39. Schofield, L., Ferreira, A., Altszuler, R., Nussenzweig, V. and Nussenzweig, R. S., Interferon-gamma inhibits the intrahepatocytic development of malaria parasites in vitro. J. Immunol. 1987. 139: 2020-2025.
40. + T cells and antibodies required for immunity to malaria sporozoites. Nature 1987. 330: 664-666.
41. + T cells. J. Exp. Med. 1994. 180: 353-358.
42. + T cell-, interferon gamma-, and nitric oxide-dependent immunity. J. Exp. Med. 1996. 183: 1739-1746.
43. Mellouk, S., Maheshwari, R. K., Rhodes-Feuillette, A., Beaudoin, R., Bergivuier, N., Matile, H., Miltgen, F., Landau, I., Pied, S., Chigot, J., Friedman, R. N. and Mazier, D., Inhibitory activity of interferons and interleukin 1 on the development of Plasmodium falciparum in human hepatocyte cultures. J. Immunol. 1987. 139: 4192-4195.
44. Ferreira, A., Schofield, L., Enea, V., Schellekens, H., van der Meide, P., Collins, W. E., Nussenzweig, R. S. and Nussenzweig, V., Inhibition of development of exoerythrocytic forms of malaria parasites by interferon-gamma. Science 1986. 232: 881-884.
45. Mellouk, S., Green, S., Nacy, C. and Hoffman, S. L., IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism. J. Immunol. 1991. 146: 3971-3976.
46. Renggli, J., Hahne, M., Matile, H., Betschart, B., Tschopp, J. and Corradin, G., Elimination of P. berghei liver stages is independent of Fas (CD95/Apo-1) or perforin-mediated cytotoxicity. Parasite Immunol. 1997. 19: 145-148.
47. + memory T cells. J. Exp. Med. 1997. 186: 859-865.
48. Robson, K. J. H., Hall, J. R. S., Davies, L. C., Crisanti, A., Hill, A. V. S. and Wellems, T. E., Polymorphism of the TRAP gene of Plasmodium falciparum. Proc. R. Soc. Lond. B 1990. 242: 205-216.
49. Robson, K. J. H., Dolo, A., Hackford, I. R., Doumbo, O., Richards, M. B., Keita, M. M., Sidibi, T. A. B., Modiano, D. and Crisanti, A., Natural polymorphism of the thrombospondin-related adhesive protein of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 1998. 58: 81-89.
50. Hill, A. V. S., Allsopp, C. E. M., Kwiatkowski, D., Anstey, N. M., Twumas, I. P., Rowe, P. A., Bennett, S., Brewster, D., McMichael, A. J. and Greenwood, B. M., Common West African HLA antigens are associated with protection from severe malaria. Nature 1991. 352: 595-600.
51. de la Cruz, V. F., Lal, A. A. and McCutchan, T. F., Sequence variation in the putative functional domains of the circumsporozoite protein of Plasmodium falciparum. J. Biol. Chem. 1987. 262: 11935-11939.
52. + clones from a malaria-immunized volunteer. Science 1989. 246: 1603-1606.
53. Good, M. F., Miller, L. H., Kumar, S., Quakyi, I. A., Keister, D., Adams, J. H., Moss, B., Berzofsky, J. A. and Carter, R., Limited immunological recognition of critical malaria vaccine candidate antigens. Science 1988. 242: 574-577.
54. Good, M. F., Kumar, S., Miller, L. H., The real difficulties for malaria sporozoite vaccine development: nonresponsiveness and antigenic variation. Immunol. Today 1988. 9: 351-355.
55. de la Cruz, V. F., Maloy, W. L., Miller, L. H., Good, M. F. and McCutchan, T. F., The immunologic significance of variation within malaria circumsporozoite protein sequences. J. Immunol. 1989. 142: 3568-3575.
56. Plebanski, M., Lee, E. A. M. and Hill, A. V. S., Immune evasion in malaria: altered peptide ligands of the circumsporozoite protein. Parasitology 1997. 115: 1-12.
57. de la Cruz, V. F., Maloy, W. L., Miller, L. H., Lal, A. A., Good, M. F. and McCutchan, T. F., Lack of cross-reactivity between variant T cell determinants from malaria circumsporozoite protein. J. Immunol. 1988. 141: 2456-2460.
58. Plebanski, M., Gilbert, S. C., Gupta, S., Morris, J., Cox, M., Aidoo, M., Kwiatkowski, D., Greenwood, B. M., Whittle, H. C. and Hill, A. V. S., Association of a malaria parasite population structure, HLA, and immunological antagonism. Science 1998. 279: 1173-1177.
59. Doolan, D. L. and Hoffman, S. L., Multi-gene vaccination against malaria: a multistage, multi-immune response approach. Parasitol. Today 1997. 13: 171-178.
60. Kwiatkowski, D. and Marsh, K., Development of a malaria vaccine. Lancet 1997. 350: 1696-1701.
61. Allsopp, C. E. M., Plebanski, M., Gilbert, S., Sinden, R. E., Harris, S., Frankel, G., Dougan, G., Hioe, C., Nixon, D., Paoletti, E., Layton, G. and Hill, A. V. S., Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization. Eur. J. Immunol. 1996. 26: 1951-1959.
62. Moss, B., Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proc. Natl. Acad. Sci. USA 1996. 93: 11341-11348.
63. Sedegah, M., Jones, T. R., Kaur, M., Hedstrom, R., Hobart, P., Tine, J. A. and Hoffman, S. L., Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine. Proc. Natl. Acad. Sci. USA 1998. 95: 7648-7653.
64. Plebanski, M., Gilbert, S. C., Schneider, J., Hannan, C. M., Layton, G., Blanchard, T., Becker, M., Smith, G., Butcher, G., Sinden, R. E. and Hill, A. V. S., Protection from Plasmodium berghei infection by priming and boosting T cells to a single class-I-restricted epitope with recombinant carriers suitable for human use. Eur. J. Immunol. 1998. 28: 4345-4355.
65. Sokal, R. R. and Rohlf, J. F., Analysis of proportion. In Biometry: the principles and practice of statistics in biological research, 3rd Edn. Freeman, New York 1995, pp 60-61.
66. Davenport, M. P., Ho Shon, I. A. P. and Hill, A. V. S., An empirical method for the prediction of T-cell epitopes. Immunogenetics 1995. 42: 392-397.